Year: 2021
Fingerprint Cards AB (Fingerprints™) today announced that the company has signed a multi-year contract for its touchless (iris) solution with Mantra Softech India Pvt Ltd, the largest Indian biometric device and sensor manufacturer, exporting to more than 60 countries across the world. Fingerprints’ world-leading, high-security iris recognition solution will be used in multiple devices from Mantra Softech India Pvt Ltd in the coming years.
“We are very pleased with this contract, which confirms the positive trend in demand for touchless solutions. It demonstrates the strength of our solution, and the tight collaboration with Mantra Softech India Pvt Ltd,” comments Michel Roig, SVP Business Line Payment & Access at Fingerprints.
“The combination of Fingerprints’ cutting-edge iris solution and our proprietary hardware highly complement...
RoodMicrotec and AEM announce strategic cooperation in the Central European market
Written by Customer Service on . Posted in Public Companies.
AIOLOS BP_2021_CopyRight_MSiebert 17 12 2021The Picture Shows the AIOLOS System installed at RoodMicrotecDeventer, December 22, 2021 – RoodMicrotec N.V., a leading independent company for semiconductors supply and quality services, and AEM, a global leader in semiconductor test and handling, today announce a collaboration that will open doors for AEM’s Afore Wafer Level Test Solutions engineering team to install and exhibit the AIOLOS Wafer Level Test Handlers at the RoodMicrotec facility in Nördlingen. With this handler, RoodMicrotec will be able to offer its customers additional capabilities in the fast-growing markets of sensor and wafer-frame testing.
The AIOLOS allows test and calibration of:Pressure sensors such as those used in cell phones and other handheld devices
Gas and humidity sensors, i.e. for air quality...
Cnova NV – Changes to Board of Directors
Written by Customer Service on . Posted in Public Companies.
Cnova NV – Changes to Board of Directors
AMSTERDAM – December 22, 2021, 07:45 CET Cnova N.V. (Euronext Paris: CNV; ISIN: NL0010949392) (“Cnova” or the “Company”) announces the appointment on December 21, 2021 of Mr. Steven Geers as replacement executive board member of Cnova, following the resignation of Mr. Arnaud Strasser as non-executive board member on the same date. Mr. Geers was appointed with a term lasting until Cnova’s next general meeting of shareholders and will continue to act as the Company’s general counsel. Following these changes, Cnova’s Board of Directors will comprise 2 executive and 7 non-executive board members.
A Dutch citizen, Steven Geers was appointed as the Company’s General Counsel in March 2016, after having joined the Company in March 2015. Prior to joining the Company, Mr. Geers worked as a senior lawyer at...
Notice of Annual General Meeting of 31 January 2022
Written by Customer Service on . Posted in Public Companies.
Dear Madam, Sir,
Please find hereafter our press release regarding the notice of annual general meeting of 31 January 2022.
We remain at your entire disposal for any further information.
Yours sincerely.AttachmentsCommuniqué de pressePersberichtPress release
GORILLA TECHNOLOGY GROUP INC., A GLOBAL PROVIDER OF EDGE VIDEO ANALYTIC AI TECHNOLOGY, TO BECOME PUBLICLY TRADED THROUGH PROPOSED BUSINESS COMBINATION WITH GLOBAL SPAC PARTNERS CO.
Written by Customer Service on . Posted in Public Companies.
Gorilla’s leading Edge Analytics AI solutions are built on over 20 years of patented and proprietary technology – they run across most platforms, devices and businesses.
Gorilla anticipates a significant increase in smart infrastructure investments in the near future, with much of the spending focused on relieving post-pandemic stresses and facilitating economic recovery. The global edge computing market is expected to see massive growth in the coming years and is anticipated to reach $250 billion by 2024, exhibiting a compound annual growth rate (CAGR) of 12.5% over the forecast period, according to International Data Corporation (IDC). Gorilla is at the forefront of this growth as its early mover advantage and innovative technology place the company in a strong position to benefit from the potential growth in connected devices.
Gorilla...
A.P. Møller – Mærsk A/S expands its contract logistic capabilities through the acquisition of LF Logistics Holdings Limited, a leading omnichannel fulfilment contract logistics company in Asia Pacific.
Written by Customer Service on . Posted in Public Companies.
ANNOUNCEMENT
A.P. Møller – Mærsk A/S expands its contract logistic capabilities through the acquisition of LF Logistics Holdings Limited, a leading omnichannel fulfilment contract logistics company in Asia Pacific.
Today, A.P. Møller – Mærsk A/S (Maersk) announces that it has reached an agreement to acquire 100% of the shares in LF Logistics Holdings Limited (LF Logistics) in an all-cash deal. LF Logistics is a well-established and strongly positioned Asia-Pacific-based omnichannel fulfilment contract logistics company. The acquisition will further strengthen Maersk’s capabilities as an integrated container logistics company, offering global end-to-end supply chain solutions to its customers.
LF Logistics is a private Hong Kong based company owned by Li & Fung (78.3%) and Temasek Holdings (21.7%) that focuses on providing...
Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA
Written by Customer Service on . Posted in Public Companies.
Submission is supported by comprehensive package of analytical, pre-clinical and clinical data, proposed biosimilar trastuzumab developed by EirGenix, Inc.Breast cancer is one of most common types of cancer in women, accounting for over 355,000 new cases in 2020 in Europe alone1Sandoz has been developing and providing oncology medicines for over 30 years, to expand access to and increase affordability of high quality medicinesBasel, December 22, 2021 — Sandoz, a global leader in generic and biosimilar medicines, today announced that it has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150 mg, for intravenous use) developed by EirGenix, Inc. to the European Medicines Agency (EMA).
Trastuzumab is a monoclonal antibody used for the treatment of human epidermal growth factor receptor 2 positive...
Celyad Oncology Announces January 2022 Conference Schedule
Written by Customer Service on . Posted in Public Companies.
MONT-SAINT-GUIBERT, Belgium, Dec. 22, 2021 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the Company plans to participate virtually in the following conference in January 2022:
H.C. Wainwright BioConnect 2022 ConferenceDates: Monday, January 10 to Thursday, January 13, 2022Presentation: On-demand starting January 10, 7 a.m. ET / 1 p.m. CETPresenter: Filippo Petti, CEO
About Celyad Oncology SA
Celyad Oncology SA is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized)...
EXTRAORDINARY GENERAL MEETING OF SIKA AG
Written by Customer Service on . Posted in Public Companies.
Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules
EXTRAORDINARY GENERAL MEETING OF SIKA AG
On January 25, 2022, an extraordinary shareholders’ meeting of Sika will be held.
The Board of Directors proposes to the extraordinary general meeting to increase the existing conditional capital from currently CHF 155,893.20, corresponding to 15,589,320 registered shares with a par value of CHF 0.01 each, to CHF 187,893.20, corresponding to 18,789,320 registered shares with a par value of CHF 0.01 each and to amend the respective clause of the Articles of Association accordingly.
The proposal is made against the background of the two convertible instruments that Sika has outstanding. The mandatory convertible bond will be converted in shares issued from the existing conditional share capital on January...
IMCD Australia & New Zealand strengthen its home care and water treatment portfolios with the acquisition of RPL Trading
Written by Customer Service on . Posted in Mergers And Acquisitions.
Photo_IMCD Australia & New Zealand strengthen its home care and water treatment portfolios with the acquisition of RPL TradingIn the picture (from left to right), Russel McNab, Managing Director, RPL Trading; Martin Stoemmer, Managing Director, IMCD Australia & New Zealand; Melissa Cardamone, Finance Director, IMCD Australia & New Zealand; Lindsay Roberts, Managing Director, RPL TradingROTTERDAM, The Netherlands (22 December 2021) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Australia & New Zealand have signed an agreement to acquire 100% of the shares of RPL Trading Pty Ltd and RPL Trading New Zealand Ltd. (jointly “RPL Trading”).
“RPL Trading brings an excellent and highly complementary portfolio of suppliers, products,...